
Loading, please wait...

Loading, please wait...

Researchers recently introduced a significant innovation in sucralose purification with CD-MOFs. This development focuses on using edible β-cyclodextrin metal-organic frameworks (CD-MOFs) to enhance the production and application of sucralose. As a zero-calorie sweetener, sucralose remains vital for diabetes management. However, maintaining high purity while controlling release rates presents a major challenge in food science.
The study compared potassium (K) and sodium (Na) based β-cyclodextrin frameworks. Significantly, the potassium-based version showed a superior loading capacity for sucralose. Furthermore, decreasing the particle size to below 8.56 μm allowed for a loading ratio of 18.00%. Nano-sized frameworks also demonstrated an impressive controllable release profile. For instance, only 41.12% of the sweetener left the framework after a 24-hour period. This performance stems from coordination-driven ligand exchange where stronger K-Cl bonds replace weak K-O bonds.
A critical phase of sucralose production involves removing unwanted by-products. The research highlights that β-CD-MOFs can selectively adsorb DH-4,1'-DGS, which is the primary by-product of production. Consequently, the material achieves a high separation factor of 21.39. This remarkable sucralose purification with CD-MOFs occurs because the by-product has a smaller molecular size and less steric hindrance. Therefore, these edible frameworks provide a cost-effective and highly efficient method for refining artificial sweeteners.
India faces a growing prevalence of metabolic disorders like diabetes. Consequently, the demand for high-purity artificial sweeteners is rising steadily. Improving production processes ensures that patients receive products with significantly fewer synthesis by-products. These edible and biodegradable materials align with global safety standards for food additives. Moreover, the simultaneous loading and purification capabilities on cheap substrates could reduce manufacturing costs for pharmaceutical and nutrition sectors.
CD-MOFs consist of β-cyclodextrin and alkali metals like potassium. These components are edible, biodegradable, and generally recognized as safe (GRAS). Their porous structure allows them to capture and release specific molecules efficiently.
During sucralose synthesis, various chlorinated by-products like DGS form. This sucralose purification with CD-MOFs method eliminates these impurities. Consequently, the process improves the safety profile and quality of the final sweetener used in medicines and foods.
Research indicates that smaller particle sizes, particularly nano-sized frameworks, offer better loading capacity. This allows for more precise applications in functional foods and advanced drug delivery systems.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or substitute for professional healthcare consultation. Refer to the latest local and national guidelines for clinical practice.
References
Jie H et al. Coordination-driven high sucralose loading, releasing and purifying performance of edible β-cyclodextrin metal-organic frameworks. J Sci Food Agric. 2026 Mar 10. doi: 10.1002/jsfa.70572. PMID: 41807283.
Magnuson BA et al. Critical review of the current literature on the safety of sucralose. Food Chem Toxicol. 2017 Aug;106(Pt A):324-355.
Singh RK et al. Native Cyclodextrin-Based Metal-Organic Frameworks (MOFs): Synthesis, Characterization, and Potential Applications in Food Industry. Foods. 2024 Nov;13(22):3645.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Researchers developed edible β-cyclodextrin frameworks to improve sucralose loading, release, and purification, offering a cheap, efficient refining method....
6 months ago

Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today

Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday

Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today